Immunohistochemistry Market: Latest Trends, Technological Advancements, Driving Factors, and Forecast until 2029
The global immunohistochemistry market, valued at US$3.4B in 2023, is forecasted to grow at a 7.2% CAGR, reaching US$3.7B by 2024 and US$5.2B by 2029.
The global Immunohistochemistry Market is valued at an estimated USD 3.4 billion in 2024 and is projected to reach USD 5.2 billion by 2029 at a CAGR of 7.2% during the forecast period. The global Immunohistochemistry (IHC) market is driven by the rising incidence of cancer, which increases the demand for accurate diagnostic tools like IHC tests. Innovations in antibodies and automated equipment have improved the accuracy and efficiency of cancer detection, while the growing adoption of personalized treatment plans presents significant opportunities. However, alternative technologies such as in situ hybridization, NGS, and RNA sequencing pose challenges to IHC market growth. The rise of digital pathology, offering benefits like reduced turnaround times and improved workflow, further supports market expansion. Nevertheless, the lack of standardization in IHC products limits growth, though ongoing efforts to address this issue are underway. Companion diagnostics, which tailor treatments to individual patients, also present opportunities for market growth. Despite competition from alternative methods, the IHC market continues to grow, with significant contributions from major players like F. Hoffmann-La Roche, Danaher Corporation, and Agilent Technologies. The diagnostic applications segment holds the largest market share, driven by the increasing need for accurate disease diagnosis, while antibodies remain the most significant product segment. Hospitals and diagnostic laboratories are the primary end users, with North America experiencing notable growth due to advanced diagnostic infrastructure and high disease prevalence.
Download PDF Brochure:
Browse in-depth TOC on " Immunohistochemistry Market"
666 - Tables
63 - Figures
489 - Pages
F. Hoffmann-La Roche AG: Leading Innovator in Immunohistochemistry
F. Hoffmann-La Roche AG (Switzerland) stands out as a major player in the global immunohistochemistry (IHC) market. Operating through its Pathology Lab segment within the Diagnostics Division, Roche provides a comprehensive range of IHC products, including the BenchMark ULTRA IHC/ISH System and the OptiView DAB IHC Detection Kit. The company has reinforced its market position with the launch of new and improved products, such as the BenchMark ULTRA PLUS system, the VENTANA DP 600 slide scanner, the Elecsys anti-p53 Immunoassay, and the VENTANA ALK (D5F3) CDx Assay. Roche's global reach spans Europe, the Middle East & Africa, North America, Asia Pacific, and Latin America.
Danaher Corporation: Pioneering Solutions in Immunohistochemistry
Danaher Corporation (US) excels in the IHC market through its subsidiary Leica Biosystems. This division, part of the Anatomical Pathology Diagnostics and Core Lab Diagnostics segments, offers a wide array of chemical and immuno-staining instruments, reagents, and consumables. Danaher's market leadership is attributed to its extensive customer base, advanced technology, significant R&D investments—amounting to USD 1.50 billion in 2023—and collaborations with research institutions and clinicians worldwide. Notable developments include a partnership with Navinci for advanced cancer research and the acquisition of Cell IDx, Inc., enhancing Danaher's competitive edge in the IHC market.
Agilent Technologies, Inc.: Key Contributor to IHC Diagnostics
Agilent Technologies, Inc. (US) is a significant player in the IHC market, focusing on cancer diagnostics and anatomic pathology workflows through its Pathology Solutions segment. The company expanded its offerings with partnerships like the one with Incyte for companion diagnostic solutions and with Akoya Biosciences for chromogenic and immunofluorescent multiplex assays. Agilent is also broadening its global footprint with a new Center for Excellence in India and maintains a strong presence in regions including the US, UK, Australia, China, Germany, and Japan, among others.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121632939
Product Segment: Antibodies Drive Immunohistochemistry Market Growth
The immunohistochemistry (IHC) market is categorized into antibodies, reagents, equipment, and kits. In 2023, antibodies dominated the market, driven by advancements in immunohistochemistry that boost R&D activities for various antibodies. The high demand for primary antibodies, which are essential for IHC protocols and widely used in diagnostic and research applications, supports this segment. Additionally, the growth is fueled by increasing adoption of targeted immunotherapy, heightened awareness of healthcare diagnostics, rising approval rates for therapeutic antibodies, and increased R&D spending by pharmaceutical and biotechnology companies.
Application Segment: Research Applications Contribute Significantly
The IHC market is segmented by application into diagnostic, research, and forensic uses. The research application segment held the second-largest share in 2023. High-throughput automated IHC platforms are utilized in research to ensure consistent staining across slides, crucial for studying drug effects on tissues at the molecular level. IHC products are also vital for identifying drug-induced toxic effects and studying embryonic development, including stem cell differentiation. These factors make IHC techniques essential in developmental studies, stem cell research, and drug testing, thereby contributing to the segment's significant market share.
End-User Segment: Academic and Contract Research Organizations Lead
The IHC market is divided by end users into hospitals & diagnostic laboratories, academic & contract research organizations (CROs), and other entities such as pharmaceutical & biotechnology companies and forensic laboratories. In 2023, academic & CROs represented the second-largest segment. IHC techniques are extensively used for identifying and validating pharmaceutical targets, analyzing tumor-stroma-immune cell interactions, and categorizing patients in clinical trials. The growing demand for personalized cancer treatments, increased application of IHC in drug development, and rising investments in life sciences research drive this segment's expansion.
Regional Insights: North America Dominates the Market
The IHC market is segmented by region into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America led the market in 2023, supported by ongoing economic development, rising healthcare expenditure, and improved access to advanced cancer screening technologies. The region benefits from favorable reimbursement policies for pathology diagnostic tests and high-quality healthcare infrastructure, which further drives the growth of the IHC market.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
40 minutes ago
- Globe and Mail
Stock Market Today: Tech Weakness Pulls S&P 500, Nasdaq Lower as Dow Holds Steady
U.S. stocks finished mixed on Tuesday as a sell-off in tech stocks weighed on the broader market. The S&P 500 (SNPINDEX: ^GSPC) fell 37.78 points, or 0.6%, to 6,411.37, while the Nasdaq Composite (NASDAQINDEX: ^IXIC) tumbled 314.82 points, or 1.5%, to 21,314.95. Semiconductor shares led the decline as Nvidia (NASDAQ: NVDA) lost 3.5%, Advanced Micro Devices (NASDAQ: AMD) dropped 5.4%, and Broadcom (NASDAQ: AVGO) slipped 3.6%. Software maker Palantir (NASDAQ: PLTR) plunged more than 9%, making it the S&P 500's weakest performer. The Dow Jones Industrial Average (DJINDICES: ^DJI) bucked the trend, edging up 10.45 points, or 0.02%, to 44,922.27. Gains in financials and industrials offset pressure from technology, allowing the blue-chip benchmark to close slightly higher. The day's divergence across indices underscored investors' rotation toward value and dividend-paying stocks, even as markets brace for upcoming economic data and fresh commentary from the Federal Reserve later this week. Market data sourced from Google Finance and Yahoo! Finance on Tuesday, Aug. 19, 2025. Should you invest $1,000 in S&P 500 Index right now? Before you buy stock in S&P 500 Index, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and S&P 500 Index wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,466!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,633!* Now, it's worth noting Stock Advisor's total average return is 1,077% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Daily Stock News has no position in any of the stocks mentioned. This article was generated with GPT-4o, OpenAI's large-scale language generation model and has been reviewed by The Motley Fool's AI quality control systems. The Motley Fool has positions in and recommends Advanced Micro Devices, Nvidia, and Palantir Technologies. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy.
The Province
2 hours ago
- The Province
For sale: A used U.S.-Canada border crossing goes on the auction block
An online auction for the property starts on Wednesday, Aug. 20 with an asking price of US$25,000 Former U.S Customs border entry facility in Madawaska, Maine on the Saint John River. Photo by U.S. Government Services Administration The U.S. government is selling a former border crossing facility in Madawaska, Maine, across from Edmunston, New Brunswick. This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Exclusive articles by top sports columnists Patrick Johnston, Ben Kuzma, J.J. Abrams and others. Plus, Canucks Report, Sports and Headline News newsletters and events. Unlimited online access to The Province and 15 news sites with one account. The Province ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles and comics, including the New York Times Crossword. Support local journalism. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Exclusive articles by top sports columnists Patrick Johnston, Ben Kuzma, J.J. Abrams and others. Plus, Canucks Report, Sports and Headline News newsletters and events. Unlimited online access to The Province and 15 news sites with one account. The Province ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles and comics, including the New York Times Crossword. Support local journalism. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors An online auction for the property starts on Wednesday, Aug. 20. The asking price is US$25,000. Bidding for the old Port of Entry (POE) will increase in $1,000 increments, says the U.S. General Services Administration in a press release about the sale. (The GSA is the U.S. government's shared services arm, managing a real estate portfolio of over 360 million rentable square feet.) The site of the former U.S Customs border entry facility in Madawaska, Maine on the Saint John River. Photo by U.S. Government Services Administration The almost one-acre property is located along the Saint John River. The intention behind the sale seems to be for a buyer to simply convert it into a local business. While the commercial space listing has primarily been used as an office, the real estate ad suggests other potential purposes: m anufacturing, warehouse, storage facility, garage/shop. Essential reading for hockey fans who eat, sleep, Canucks, repeat. By signing up you consent to receive the above newsletter from Postmedia Network Inc. Please try again This advertisement has not loaded yet, but your article continues below. 'GSA is transforming an underutilized border facility into an opportunity for community and economic development,' said Public Buildings Service Regional Commissioner Glenn C. Rotondo in the release. The former U.S Customs border entry facility in Madawaska, Maine on the Saint John River. Photo by U.S. Government Services Administration The first floor of the building is 2,900 square feet. There is also a 2,900 square foot finished basement. The southern portion of the property is flat, paved and has a one-storey brick building with two canopies, a guard shack and shed for a generator. The northern half of the property is on a floodplain and can't be built upon. Instead, it consists of a steep, wooded slope leading from a retaining wall down approximately 50 feet to the water line of the Saint John River. The river surrounds the northern edge of the property. A paper mill with a rail line is situated on the other perimeters. This advertisement has not loaded yet, but your article continues below. The 1959 facility was closed last year when U.S. Customs and Border Protection ceased operations there and relocated to the new Madawaska POE and International Bridge. The new facility will include room for increases in traffic. The new facility, worth roughly $73 million, is also aiming to be include administrative offices and training space. Parts of the old bridge were saved by the town, according to Maine newspaper The County. A local artist pitched a plan to create a 20-foot sculpture of an Acadian star out of materials from the bridge to celebrate the Francophone cultural connection shared by the two countries, across the old bridge created. Acadians are descendants of French settlers who originally settled in Canada's Maritime Provinces in the 17th and 18th centuries. Aroostook County later became a hub of Acadian culture, with a large population still maintaining their heritage. The invitation for bids and additional information about the property can be found on the auction webpage. Only registered bidders will be allowed to inspect the property by appointment. Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here. Local News NHL News Opinion News
Toronto Star
3 hours ago
- Toronto Star
Enthusiast Gaming Announces Updates on Divestment of Direct Sales Business
TORONTO, Aug. 19, 2025 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. ('Enthusiast Gaming' or the 'Company') (TSX:EGLX) today announced that it has entered into a binding letter of intent (the 'Binding LOI') with Vertiqal Studios Corp. ('VSC') pursuant to an unsolicited offer from VSC to acquire the direct sales business carried on by the Company (the 'Direct Sales Business Line'). The entities and assets to be acquired in the transaction (the 'Transaction') are the same as those set out in the Company's prior announcement in respect of the divestment of the Direct Sales Business Line on July 7, 2025 (the 'July 7 Press Release'). Prior to entering into the Binding LOI with VSC, the Company terminated its existing non-binding letter of intent in respect of the Direct Sales Business Line as set out in the July 7 Press Release. Under the terms of the Transaction, VSC will acquire the Direct Sales Business Line and related acquired entities for cash consideration of C$900,000, which has been paid to the Company as a non-refundable deposit to secure the Transaction, as well as the assumption of all existing and ongoing liabilities of the Direct Sales Business Line and acquired entities as of the closing date. As of June 30, 2025, the net liability position of the Direct Sales Business Line and acquired entities being assumed by VSC would have been approximately US$2.6 million.
